Archive | Pharmaceutical RSS feed for this section

Pharmaceutical Sales Rep Calls And Sales Force Effectiveness – The Trend

There is an interesting article in PharmaLive which suggests that physicians are more satisfied now than before with the lower frequency of sales calls. In data published by SDIHealth, Pfizer was ranked number 1 in traditional detailing. Actually very few physicians or other health care professional object to sales calls as long as the calls [...]

Read full storyComments { 3 }

SME Biotechnology Companies Hit By Economic Events – Not Others Though

There is no doubt that the economic recession which has now touched all parts of the world is taking it’s toll on most industries. One of the most resilient however is the healthcare industry. Sibaya LifeScience! recently interviewed several companies supplying services to “big pharma” in the form of contract manufacturing – especially drug delivery [...]

Read full storyComments { 1 }

New FDA Publication – Guidance for Industry: Process Validation: General Principles and Practices

The United States FDA has just issued a new Guidance for Industry: Process Validation: General Principles and Practices This is an important new proposed guideline document and the FDA is inviting comments within 60 days of it being published in the register. Our initial observations at Sibaya LifeScience! are: Aligning process validation activities with the [...]

Read full storyComments { 3 }

Health Robotics And Devon International Agreement On Cytocare (TM)

(Here is a good example of how robotics in Lifesciences can both increasingly achieve cost efficiencies but also enhanced safety and regulatory compliance (see previous post from Sibaya at Emballage 2008.) Health Robotics and Devon International Group have entered into an agreement where DIG and ITOCHU have acquired substantial exclusive manufacturing, marketing and other rights [...]

Read full storyComments { 1 }

BD (Becton Dickinson) On A Roll

While many business are slashing dividends BD continues to increase their dividend for the 36th continuous year. They also announced a stock repurchase program. “This marks the 36th consecutive year of BD dividend increases. We continue to generate strong cash flow, allowing us to return significant dollars to our shareholders while continuing to make investments [...]

Read full storyComments { 0 }